During the past decade, Memorial Hospital West conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 31 clinical trials were completed, i.e. on average, 58.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 27 clinical trials were completed. i.e. 245.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Hospital West" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "SWOG Cancer Research Network" with 13 trials sponsored, "Pfizer" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Hospital West" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Medivation, Inc." with 3 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Hospital West" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (5 trials), "Colorectal Cancer" (4 trials) and "Stage II Breast Cancer" (4 trials). Many other conditions were trialed in "Memorial Hospital West" in a lesser frequency.

Most popular intervention types in "Memorial Hospital West" are "Drug" (51 trials), "Other" (38 trials), "Biological" (22 trials), "Procedure" (13 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Nivolumab" (9 trials), "Quality-of-Life Assessment" (9 trials), "Cisplatin" (8 trials) and "Docetaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Hospital West" are 63 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Memorial Hospital West". undefined are not yet recruiting, 13 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Memorial Hospital West, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Hospital West, 2 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Memorial Hospital West has several departments that took part in Clinical trials: "Memorial Cancer Institute at Memorial Regional Hospital" - 140 trials, "Memorial Breast Cancer Center at Memorial Hospital West" - 7 trials